PETER GUZZETTI: Open Payments
NPI 1306885207 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 85 payments from 20 companies in 2025. Trend: 2023 $2,165 · 2024 $1,943 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 29 | $362 |
| Lundbeck LLC | 7 | $209 |
| AstraZeneca Pharmaceuticals LP | 8 | $155 |
| Novo Nordisk Inc | 5 | $117 |
| Amgen Inc. | 6 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Corcept Therapeutics | 2 | $64 |
| Exact Sciences Corporation | 3 | $59 |
Products named: REXULTI, ELIQUIS, PAXLOVID, BREZTRI, EVENITY, PREVNAR 20, TRINTELLIX, JARDIANCE.
Industry payments across ME — which companies pay providers there.
